Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001656472-22-000005
Filing Date
2022-01-12
Accepted
2022-01-12 18:44:01
Documents
3
Period of Report
2022-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164203102635951.html 3  
1 FORM 3 wf-form3_164203102635951.xml 3 2383
2 EXHIBIT LIST: EXHIBIT 24 - POWER OF ATTORNEY (GRIESE) cronossection16poa_jgxsi.htm EX-24 692
3 EXHIBIT LIST: EXHIBIT 24 - POWER OF ATTORNEY (GRIESE) cronossection16poa_jgxsi001.jpg GRAPHIC 124520
  Complete submission text file 0001656472-22-000005.txt   176193
Mailing Address 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1
Business Address 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1 (416) 504-0004
Cronos Group Inc. (Issuer) CIK: 0001656472 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2H1
Business Address
Griese John (Reporting) CIK: 0001901341 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38403 | Film No.: 22527496